|
1
|
Pathak D, Agrawal S and Dhali TK:
Prevalences of and risk factors for vulvar diseases in Nepal: A
hospital-based study. Int J Dermatol. 50:161–167. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Akhtar-Danesh N, Elit L and Lytwyn A:
Trends in incidence and survival of women with invasive vulvar
cancer in the United States and Canada: A population-based study.
Gynecol Oncol. 134:314–318. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dittmer C, Katalinic A, Mundhenke C, Thill
M and Fischer D: Epidemiology of vulvar and vaginal cancer in
Germany. Arch Gynecol Obstet. 284:169–174. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Judson PL, Habermann EB, Baxter NN, Durham
SB and Virnig BA: Trends in the incidence of invasive and in situ
vulvar carcinoma. Obstet Gynecol. 107:1018–1022. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen CZ, Li L, Lodish HF and Bartel DP:
MicroRNAs modulate hematopoietic lineage differentiation. Science.
303:83–86. 2004. View Article : Google Scholar
|
|
6
|
Sharma A, Kumar M, Aich J, Hariharan M,
Brahmachari SK, Agrawal A and Ghosh B: Posttranscriptional
regulation of interleukin-10 expression by hsa-miR-106a. Proc Natl
Acad Sci USA. 106:5761–5766. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
de Melo Maia B, Lavorato-Rocha AM,
Rodrigues LS, Coutinho-Camillo CM, Baiocchi G, Stiepcich MM, Puga
R, de A Lima L, Soares FA and Rocha RM: microRNA portraits in human
vulvar carcinoma. Cancer Prev Res (Phila). 6:1231–1241. 2013.
View Article : Google Scholar
|
|
9
|
Pecorelli S: Revised FIGO staging for
carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol
Obstet. 105:103–104. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee
DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, et al:
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic
Acids Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li Y, Wang F, Xu J, Ye F, Shen Y, Zhou J,
Lu W, Wan X, Ma D and Xie X: Progressive miRNA expression profiles
in cervical carcinogenesis and identification of hPV-related target
genes for miR-29. J Pathol. 224:484–495. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen ZL, Zhao XH, Wang JW, Li BZ, Wang Z,
Sun J, Tan FW, Ding DP, Xu XH, Zhou F, et al: microRNA-92a promotes
lymph node metastasis of human esophageal squamous cell carcinoma
via E-cadherin. J Biol Chem. 286:10725–10734. 2011. View Article : Google Scholar :
|
|
13
|
Jiang X, Xiang G, Wang Y, Zhang L, Yang X,
Cao L, Peng H, Xue P and Chen D: MicroRNA-590–5p regulates
proliferation and invasion in human hepatocellular carcinoma cells
by targeting TGF-β RII. Mol Cells. 33:545–551. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hirata H, Ueno K, Shahryari V, Tanaka Y,
Tabatabai ZL, Hinoda Y and Dahiya R: Oncogenic miRNA-182-5p targets
Smad4 and RECK in human bladder cancer. PLoS One. 7:e510562012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Garzon R, Fabbri M, Cimmino A, Calin GA
and Croce CM: MicroRNA expression and function in cancer. Trends
Mol Med. 12:580–587. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Eulalio A, Mano M, Dal Ferro M, Zentilin
L, Sinagra G, Zacchigna S and Giacca M: Functional screening
identifies miRNAs inducing cardiac regeneration. Nature.
492:376–381. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Watson JA, Bryan K, Williams R, Popov S,
Vujanic G, Coulomb A, Boccon-Gibod L, Graf N, Pritchard-Jones K and
O'Sullivan M: miRNA profiles as a predictor of chemorespon-siveness
in Wilms' tumor blastema. PLoS One. 8:e534172013. View Article : Google Scholar
|
|
18
|
Chu Y, Ouyang Y, Wang F, Zheng A, Bai L,
Han L, Chen Y and Wang H: MicroRNA-590 promotes cervical cancer
cell growth and invasion by targeting ChL1. J Cell Biochem.
115:847–853. 2014. View Article : Google Scholar
|
|
19
|
Xiao X, Tang C, Xiao S, Fu C and Yu P:
Enhancement of proliferation and invasion by microRNA-590-5p via
targeting PBRM1 in clear cell renal carcinoma cells. Oncol Res.
20:537–544. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ekhteraei-Tousi S, Mohammad-Soltani B,
Sadeghizadeh M, Mowla SJ, Parsi S and Soleimani M: Inhibitory
effect of hsa-miR-590-5p on cardiosphere-derived stem cells
differentiation through downregulation of TGFB signaling. J Cell
Biochem. 116:179–191. 2015. View Article : Google Scholar
|
|
21
|
Shan X, Miao Y, Fan R, Qian H, Chen P, Liu
H, Yan X, Li J and Zhou F: MiR-590-5P inhibits growth of hepg2
cells via decrease of S100A10 expression and Inhibition of the Wnt
pathway. Int J Mol Sci. 14:8556–8569. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ji Q, Liu X, Han Z, Zhou L, Sui H, Yan L,
Jiang H, Ren J, Cai J and Li Q: Resveratrol suppresses
epithelial-to-mesenchymal transition in colorectal cancer through
TGF-β1/Smads signaling pathway mediated Snail/E-cadherin
expression. BMC Cancer. 15:972015. View Article : Google Scholar
|
|
23
|
Guo W, Zhang M, Shen S, Guo Y, Kuang G,
Yang Z and Dong Z: Aberrant methylation and decreased expression of
the TGF-β/Smad target gene FBXO32 in esophageal squamous cell
carcinoma. Cancer. 120:2412–2423. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Goto N, Hiyoshi H, Ito I, Iida K, Nakajima
Y, Nagasawa K and Yanagisawa J: Identification of a novel compound
that suppresses breast cancer invasiveness by inhibiting
transforming growth factor-β signaling via estrogen receptor α. J
Cancer. 5:336–343. 2014. View
Article : Google Scholar
|
|
25
|
Ischenko I, Liu J, Petrenko O and Hayman
MJ: Transforming growth factor-beta signaling network regulates
plasticity and lineage commitment of lung cancer cells. Cell Death
Differ. 21:1218–1228. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ganapathy A, Paterson IC, Prime SS, Eveson
JW, Pring M, Price N, Threadgold SP and Davies M: TGF-β inhibits
metastasis in late stage human squamous cell carcinoma of the skin
by a mechanism that does not involve Id1. Cancer Lett. 298:107–118.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Deacu E, Mori Y, Sato F, Yin J, Olaru A,
Sterian A, Xu Y, Wang S, Schulmann K, Berki A, et al: Activin type
II receptor restoration in ACVR2-deficient colon cancer cells
induces transforming growth factor-beta response pathway genes.
Cancer Res. 64:7690–7696. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Paterson IC, Matthews JB, Huntley S,
Robinson CM, Fahey M, Parkinson EK and Prime SS: Decreased
expression of TGF-beta cell surface receptors during progression of
human oral squamous cell carcinoma. J Pathol. 193:458–467. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Alanazi I, Hoffmann P and Adelson DL:
MicroRNAs are part of the regulatory network that controls EGF
induced apoptosis, including elements of the JAK/STAT pathway, in
A431 cells. PLoS One. 10:e01203372015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li X, Huang K and Yu J: Inhibition of
microRNA-21 upregulates the expression of programmed cell death 4
and phosphatase tensin homologue in the A431 squamous cell
carcinoma cell line. Oncol Lett. 8:203–207. 2014.PubMed/NCBI
|
|
31
|
Place RF, Li LC, Pookot D, Noonan EJ and
Dahiya R: MicroRNA-373 induces expression of genes with
complementary promoter sequences. Proc Natl Acad Sci USA.
105:1608–1613. 2008. View Article : Google Scholar : PubMed/NCBI
|
